Renal Osteodystrophy in Children: Therapy With Vitamin D3 or 1,25 Dihydroxy-Cholecalciferol (1,25-Dhcc)

Pediatric Research - United States
doi 10.1203/00006450-198008000-00103
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Expression of 1,25-Dihydroxy Vitamin D3 Receptor in Breast Carcinoma

Journal of Histochemistry and Cytochemistry
AnatomyHistology
1998English

Failure to Heal Vitamin D-Deficiency Rickets and Suppress Secondary Hyperparathyroidism With Conventional Doses of 1,25-Dihydroxy Vitamin D3.

BMJ
1982English

Points: 1,25 Dihydroxyvitamin D3 in Psoriasis

BMJ
1986English

Treatment of Linear Scleroderma With Oral 1,25-Dihydroxyvitamin D3 (Calcitriol) in Seven Children

Pediatric Dermatology
DermatologyChild HealthPediatricsPerinatology
1999English

Evidence for 1,25-Dihydroxyvitamin D3-Independent Transactivation by the Vitamin D Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

The 1,25-Dihydroxyvitamin D3-Independent Actions of the Vitamin D Receptor in Skin

Journal of Steroid Biochemistry and Molecular Biology
Molecular MedicineCell BiologyMolecular BiologyBiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2010English

1,25-Vitamin D3 Promotes Cardiac Differentiation Through Modulation of the WNT Signaling Pathway

Endocrine Abstracts
2015English

Vitamin D Receptor Interaction With Specific DNA Requires a Nuclear Protein and 1,25-Dihydroxyvitamin D3.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1990English

P38: The Immunoregulatory Effect of 1,25‐Dihydroxy Vitamin D in Peritoneal Mononuclear Cells of Endometriosis Patients

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy